Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Lab researcher infected with Zika
mosquito
Zika virus is largely transmitted through the bite of an infected Aedes mosquito.
First known transmission of the virus through needle stick

A female laboratory researcher has become infected with Zika virus following a needle stick accident at the University of Pittsburgh. It is thought to be the first case of its kind.

The researcher pricked herself with the needle on 23 May and started having symptoms on 1 June, according to ABC News. Her symptoms have now resolved and she is reported to be doing well.

In line with recommendations, she has agreed to use insect repellant and wear long sleeves and trousers for three weeks. This is to prevent a bite from a mosquito that could then transmit the virus to another person.

The Allegheny County Health Department urged those travelling to Zika-affected countries to be cautious. Pregnant women are advised to avoid travel to those countries. It is the county's fourth case of Zika but the health department said in a statement: 'There is still no current risk of contracting Zika from mosquitos in Allegheny County.'

Zika virus is largely transmitted through the bite of an infected Aedes mosquito, which are common in warm climates. Common symptoms are fever, rashes, joint pain and conjunctivitis. Symptoms are usually very mild, lasting for several days to a week. However, contracting the virus during pregnancy can cause the serious birth defect, microcephaly.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.